Criticized at its launch for its lower efficiency compared to its competitors from Pfizer and Moderna, the AstraZeneca vaccine would actually reduce hospitalizations by 94%. The Scottish public health body looked at the hospitalization data and compared it with the vaccination data. More than a million doses of the vaccine were administered in Scotland between December 8 and February 15, 8,000 people were hospitalized during the same period. According to preliminary results, by comparing vaccinated and unvaccinated patients, the Astra Zeneca vaccine makes it possible, four weeks after the first dose, to reduce the risk of hospitalization for Covid-19 by 94%. A similar study was carried out for the Pfizer vaccine, which is said to cause an 85% drop in hospitalizations, but the data are less conclusive.
These data relate only to hospitalizations for Covid-19, therefore to the most serious forms, against which the AstraZeneca vaccine would offer significant protection. For the mildest forms, according to published studies, the vaccine remains a little less effective than its competitors.
German authorities backpedal
In Germany, a month ago, an article by Handelsblatt, citing government sources, said AstraZeneca’s vaccine was ineffective in the elderly. In reality, there was nothing to confirm this, but the data was insufficient. The government then reserved this vaccine for those under 65. The French government did the same. Mistrust then settled across the Rhine and the German authorities are now campaigning to reassure the population about this vaccine. “Safe and very effective” according to Angela Merkel’s spokesperson.